Investors & Media

Investors & Media

Welcome to our investor page

We aspire to individualize cancer medicine

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To translate this idea into reality, we have combined ground-breaking research with cutting-edge technologies to develop pioneering therapeutics for cancer and beyond. As we prove the value of our approach in the clinic, we will continue to build the partnerships, manufacturing and team required to bring individualized treatments to patients worldwide. From our roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine.


Stock Quote

Jun 4, 2020 /

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events

June 4, 2020 at 8:30 AM EDT

Jefferies Global Healthcare Conference


June 16 - June 17, 2020

Citi European Healthcare Conference


June 26, 2020

BioNTech SE Annual General Meeting (virtual)

Due to the coronavirus pandemic, the AGM had to be rescheduled and will be held virtually.

Upcoming events (more)

Press Releases

12 May 2020

BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress

6 May 2020

BioNTech Completes Acquisition of Neon Therapeutics

5 May 2020

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID..

Press releases (more)